<DOC>
	<DOCNO>NCT02815722</DOCNO>
	<brief_summary>The purpose study investigate potential interaction SP2086 Simvastatin multiple oral dos treatment healthy adult volunteer .</brief_summary>
	<brief_title>The Drug-drug Interaction SP2086 Simvastatin</brief_title>
	<detailed_description>This open-label ( volunteer know name treatment assign ) single-center cross-over study SP2086 Simvastatin healthy adult volunteer . All subject randomize two group , drug administer accord AB BA sequence . The A sequence SP2086 take 40mg qd Day1-Day 10 ; Simvastatin administer orally ( mouth ) 200mg Day 6-Day10.The B sequence Simvastatin take 40mg qd Day6-Day10 . There 5 day washout period A B . The total time trial 27 day .</detailed_description>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>Healthy volunteer body mass index ( BMI ) 19 24 Kg/m2 Had sign inform consent voluntarily . Have abnormal lab examination result change clinical significance . History current clinically significant medical illness determine Investigator . Have family history thyroid cancer , submandibular gland cancer long QT syndrome Known allergy SP2086 Glyburide excipients formulation SP2086 Glyburide . History use sulfa sulfonylurea DPPIVor GLP1 drug similar structure drug . History severe unconsciousness hypoglycemia History surgery prior screen 6 month . History blood donationâ‰¥400 mL prior screen 3 month participate blood donation , blood transfusion one month . History participate drug medical device prior screen 3 month . Within month screen use prescription drug , overthecounter drug , Chinese herbal medicine ( especially oral antidiabetic drug ) food supplement ( vitamin ) . 2 day randomization , patient ban alcohol , tobacco , reference food drink contain caffeine xanthine , vigorous exercise , factor affect drug absorption , distribution , metabolism excretion . The hepatitis B surface antigen , hepatitis c antibody , HIV antibody syphilis antibody positive . Pregnancy lactation woman , fertility male female willing contraception test . Researchers consider situation may cause participant ca n't finish study bring obvious risk subject .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>SP2086</keyword>
	<keyword>Simvastatin</keyword>
	<keyword>drug-drug interaction</keyword>
</DOC>